CSIMarket
 


Davita Inc   (DVA)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

DVA's Net Income Growth by Quarter and Year

Davita Inc 's Net Income results by quarter and year




DVA Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 230.57 126.62 249.43 234.37
III Quarter September 309.36 164.69 319.75 217.54
II Quarter June 246.38 284.62 351.03 254.87
I Quarter March 170.67 205.72 291.55 287.90
FY   956.98 781.65 1,211.76 994.68



DVA Net Income fourth quarter 2023 Y/Y Growth Comment
Davita Inc achieved in the fourth quarter 2023, above Company average Net Income rise of 82.1% year on year, to $ 230.57 millions.

Looking into fourth quarter 2023 results within Healthcare Facilities industry 3 other companies have achieved higher Net Income growth. While Davita Inc ' s Net Income jump of 82.1% ranks overall at the positon no. 215 in the fourth quarter 2023.




DVA Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 82.1 % -49.24 % 6.43 % -22.64 %
III Quarter September 87.84 % -48.49 % 46.98 % 7.86 %
II Quarter June -13.44 % -18.92 % 37.73 % -22.1 %
I Quarter March -17.04 % -29.44 % 1.27 % 51.93 %
FY   22.43 % -35.49 % 21.82 % -2.61 %

Financial Statements
Davita Inc 's fourth quarter 2023 Net Income $ 230.57 millions DVA's Income Statement
Davita Inc 's fourth quarter 2022 Net Income $ 126.62 millions Quarterly DVA's Income Statement
New: More DVA's historic Net Income Growth >>


DVA Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December -25.47 % -23.12 % -21.99 % 7.74 %
III Quarter September 25.56 % -42.14 % -8.91 % -14.65 %
II Quarter June 44.36 % 38.35 % 20.4 % -11.47 %
I Quarter March 34.79 % -17.52 % 24.4 % -4.97 %
FY (Year on Year)   22.43 % -35.49 % 21.82 % -2.61 %




Net Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #4
Healthcare Sector #24
Overall #215

Net Income Y/Y Growth Statistics
High Average Low
504.85 % 33.42 % -83.43 %
(March 31, 2014)   (Dec 31 2015)
Net Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #4
Healthcare Sector #24
Overall #215
Net Income Y/Y Growth Statistics
High Average Low
504.85 % 33.42 % -83.43 %
(March 31, 2014)   (Dec 31 2015)

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Davita Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
739.44 % 27.42 % -86.81 %
(June 30. 2013)  


DVA's IV. Quarter Q/Q Net Income Comment
In the IV. Quarter 2023 Davita Inc realized fall in Net Income from the third quarter by -25.47% to $ 230.57 millions, from $ 309.36 millions achived in the previous quarter.

As we analyse present downturn in the quarter, we must presume, that frequently IV. Quarter 2023 results appear to be softer relative to the preciding period

Within Healthcare Facilities industry 8 other companies have achieved higher Net Income quarter on quarter growth. While Davita Inc 's Net Income growth quarter on quarter, overall rank is 898.


Net Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #9
Healthcare Sector #70
Overall #898
Net Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #9
Healthcare Sector #70
Overall #898
Net Income Q/Q Growth Statistics
High Average Low
739.44 % 27.42 % -86.81 %
(June 30. 2013)  


DVA's IV. Quarter Q/Q Net Income Comment
In the IV. Quarter 2023 Davita Inc reported fall in Net Income from the third quarter by -25.47% to $ 230.57 millions, from $ 309.36 millions released a quarter before.

As we evaluate recent slump in the IV. Quarter 2023, we should assume, that frequently IV. Quarter 2023 results emerge softer relative to the preciding period

Within Healthcare Facilities industry 8 other companies have achieved higher Net Income quarter on quarter growth. While Davita Inc 's Net Income growth quarter on quarter, overall rank is 898.


Davita Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Income 12 Months Ending $ 956.98 $ 853.02 $ 708.35 $ 746.59 $ 781.64
Y / Y Net Income Growth (TTM) 22.43 % -5.69 % -33.14 % -33.69 % -35.5 %
Year on Year Net Income Growth Overall Ranking # 1005 # 1254 # 571 # 515 # 795
Seqeuential Net Income Change (TTM) 12.19 % 20.42 % -5.12 % -4.48 % -13.58 %
Seq. Net Income Growth (TTM) Overall Ranking # 813 # 1117 # 1159 # 755 # 1196




Cumulative Net Income growth Comment
Although Davita Inc 's Annual Net Income growth year on year were below company's average 27.38% , Net Income announced in the Dec 31 2023 period, show improvement in Net Income trend, to cumulative trailing twelve month growth of 22.43% year on year, from -5.69% in Sep 30 2023.

In the Healthcare sector 72 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 1005, from total ranking in previous quarter at 1254.

Net Income TTM Q/Q Growth Statistics
High Average Low
437.34 %
27.38 %
-60.19 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 11
Healthcare Sector # 73
Overall # 1005

Net Income TTM Y/Y Growth Statistics
High Average Low
437.34 %
27.38 %
-60.19 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 63
S&P 500 # 813
Cumulative Net Income growth Comment
Although Davita Inc 's Annual Net Income growth year on year were below company's average 27.38% , Net Income announced in the Dec 31 2023 period, show improvement in Net Income trend, to cumulative trailing twelve month growth of 22.43% year on year, from -5.69% in Sep 30 2023.

In the Healthcare sector 72 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 1005, from total ranking in previous quarter at 1254.

Net Income TTM Q/Q Growth Statistics
High Average Low
437.34 %
27.38 %
-60.19 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 11
Healthcare Sector # 73
Overall # 1005

Net Income TTM Y/Y Growth Statistics
High Average Low
437.34 %
27.38 %
-60.19 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 63
S&P 500 # 813




Other Net Income Growth
Healthcare Facilities Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
DVA's Net Income Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for DVA's Competitors
Net Income Growth for Davita Inc 's Suppliers
Net Income Growth for DVA's Customers

You may also want to know
DVA's Annual Growth Rates DVA's Profitability Ratios DVA's Asset Turnover Ratio DVA's Dividend Growth
DVA's Roe DVA's Valuation Ratios DVA's Financial Strength Ratios DVA's Dividend Payout Ratio
DVA's Roa DVA's Inventory Turnover Ratio DVA's Growth Rates DVA's Dividend Comparisons



Companies with similar Net Income fall for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2023
Vericel Corporation119.40%$ 119.402 millions
Novartis Ag113.57%$ 113.573 millions
Iqvia Holdings Inc 106.61%$ 106.608 millions
Stryker Corp103.02%$ 103.020 millions
Surgery Partners Inc 100.43%$ 100.429 millions
Corcept Therapeutics Inc88.36%$ 88.364 millions
Davita Inc 82.10%$ 82.105 millions
Intuitive Surgical Inc 81.38%$ 81.378 millions
Astrazeneca Plc81.02%$ 81.020 millions
Tactile Systems Technology Inc 77.49%$ 77.494 millions
Quest Diagnostics Inc76.72%$ 76.724 millions
Dr Reddy s Laboratories Limited76.21%$ 76.206 millions
3m Company74.40%$ 74.401 millions
Electromed Inc 71.34%$ 71.341 millions
Tenet Healthcare Corp66.42%$ 66.423 millions
Alpha Pro Tech Ltd 66.36%$ 66.364 millions
Neurocrine Biosciences Inc 65.96%$ 65.955 millions
Cytek Biosciences Inc 64.76%$ 64.760 millions
United Therapeutics Corporation64.35%$ 64.345 millions
Fonar Corporation64.30%$ 64.296 millions
Select Medical Holdings Corp63.87%$ 63.868 millions
Abbott Laboratories54.31%$ 54.308 millions
Lemaitre Vascular Inc 50.44%$ 50.435 millions
Msa Safety Incorporated48.40%$ 48.401 millions
Halozyme Therapeutics Inc 47.98%$ 47.981 millions
Integer Holdings Corporation45.48%$ 45.482 millions
Cadre Holdings Inc 45.39%$ 45.386 millions
Chemed Corporation44.95%$ 44.952 millions
Viemed Healthcare Inc 42.62%$ 42.617 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com